S-GE Event
Cell & Gene Therapy
Cell & Gene Therapy

Cambridge: Cell & Gene Therapy

Both Switzerland and the United Kingdom are known for being industry leaders in all aspects related to Cell and Gene Therapy. It is for this reason that our Swiss delegation to the University of Cambridge aims to promote the exchange of best practices and key learnings from their respective ecosystems.

Novartis has recently announced its intent to invest up to 90 million Swiss francs to build a production facility for innovative cell and gene therapies in Stein in the canton of Aargau. What does this mean for Switzerland's research landscape? And how can the United Kingdom profit from this? We are bringing the UK- and Swiss-based ecosystems together for a joint discussion on current key topics with regards to R&D, business opportunities and future ambitions. Join us for an afternoon filled with exciting  presentations and networking opportunities in one of the world's most prestigious Universities.

Intro

Information

Date
Target audience Swiss Exporters, Associations, Clusters, Decision / Policy Makers, Swiss and UK-based Government, Innovation Communities (Startups & intermediaries), Academics, Industry Experts
Organizer Swiss Business Hub UK + Ireland, Switzerland Global Enterprise
Event language

English

Place

Cambridge Building
Babraham Research Campus
Cambridge
CB22 3AT
United Kingdom

Cost of participating CHF 670 (Gold Members), CHF 750 (Silver Members), CHF 790 (Non-Members)
Program

Program

Program

Welcome

Ms. Natalie Thomas

Head of the Swiss Business Hub UK + Ireland

Welcome Address

Mr. Markus Leitner

Ambassador of Switzerland to the United Kingdom

Welcome Address

Mr. George Freeman MP (TBC)

UK Minister of Science, Research & Innovation

Presentation: Stevenage Life Sciences research and R&D cluster

Ms. Kasia Averall

Head of Cluster Development at Cell and Gene Therapy Catapult

Presentation: The UK Cell & Gene Therapy ecosystem

Prof. Cedric Ghevaert

Cambridge Stem Cell Institute & Consultant Haemotologist for NHS Blood and Transplant

Presentation: The Swiss Cell & Gene Therapy ecosystem

Prof. Dr. Simon P. Hoerstrup

Chair & Director at Institute for Regenerative Medicine (IREM), Founding Co-Director at Wyss Translational Center Zurich, University of Zurich and ETH Zurich

Break

Presentation: How to start Cell & Gene Therapies in Switzerland

Dr. George Coukos

Director of Oncology University Hospital of Lausanne & Branch Director at Ludwig Cancer Research

Panel Discussion: Common challenges in introducing Cell & Gene Therapies

Dr. Stephen Ward

Chief Manufacturing Officer at The Cell and Gene Therapy Catapult

Dr. Corinne Solier

COO at Scailyte

Dr. George Coukos

Director of Oncology University Hospital of Lausanne & Branch Director at Ludwig Cancer Research

Dr. Mark Kotter

Founder & CEO of bit.bio and Stem Cell Biologist at the University of Cambridge

Dr. Anna Williamson

Executive Director, Business Development & Head of UK Business Development at Roche / Genentech

Closing Remarks

Dr. Kristin-Anne Rutter

Executive Director at the University of Cambridge

Drinks Reception

VIP Dinner

Trinity College, University of Cambridge

Invitation only 

Package

Included in the costs are:

  • Full organization of the program and coordination of local speakers / activities
  • Invitation and coordination of relevant stakeholders for networking
  • Local transportation
  • Catering
  • Networking
  • Full participation in the program

Not included:

  • Flight booking and travel costs to/from Cambridge
  • Accommodation
Contacts

Contacts

How should we contact you?
Share
How should we contact you?

Premium Partner

Strategic partners

Institutional partner

Official program